Efficacy and feasibility of endovascular therapy with drug-eluting stents for patients with arteriogenic erectile dysfunctio
Not Applicable
Recruiting
- Conditions
- erectile dysfunction
- Registration Number
- JPRN-UMIN000008915
- Lead Sponsor
- Chiba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with known other etiologies of ED 2. Untreated stenotic / occluded lesions in iliac arteries 3. Jailed internal iliac arteries by stents implanted in common / external iliac arteries 4. History of surgical treatment of iliac arteries 5. Patients with controversy for or poor adherence to dual antiplatelet therapy 6. Patients with untreated coronary artery disease 7. Patients with left ventricular dysfuinction (LVEF less than 40%) 8. Patients with severe chronic kidney disease (eg. serum creatinine level more than 2.0mg/dL)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of endovascular therapy within 6 months. The maximum score in monthly investigation of International Index of Erectile Function 5 (IIEF5, a well-known subjective classification of ED) will be compared with baseline.
- Secondary Outcome Measures
Name Time Method Efficacy of endovascular therapy at 6 months. The IIEF5 score at 6th month will be compared with baseline.